Meanwhile, ECM1, TRIB1, and CYP2C19 were downregulated, implicating impaired liver fibrosis regulation, carcinogen metabolism, and potential disruption of key signaling pathways [31–33]. The gene discussed is CYP2C19; the disease is Hepatic fibrosis.